This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hi-Tech Pharmacal, Contango Oil: Ratings Changes

TheStreet.com Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its "safety first" approach to investing aims to reduce risk while seeking total return performance.

BOSTON ( TheStreet) -- TheStreet.com's stock-rating model upgraded Hi-Tech Pharmacal (HITK - Get Report), maker of generic and over-the-counter health care products, to "buy."

The numbers: Fiscal first-quarter net income surged 478% to $8.7 million and earnings per share climbed 461% to 73 cents. Revenue grew 178% to $44 million. Its gross margin rose from 43% to 64% and its operating margin climbed from negative territory to 29%. A quick ratio of 2.4 reflects ample liquidity. The company holds minimal debt.

The stock: Hi-Tech Pharmacal has surged 250% this year, outpacing major U.S. indices. The stock trades at a price-to-earnings ratio of 13, a discount to the market and pharmaceutical peers. The company does not pay dividends.

The model downgraded Contango Oil & Gas (MCF) to "hold."

The numbers: Fiscal fourth-quarter net income dropped 80% to $5.2 million and earnings per share fell 79% to 32 cents, cushioned by a lower share count. Revenue fell 48% to $36 million. Its gross margin declined from 93% to 75% and its operating margin dropped from 79% to 24%. A quick ratio of 1.8 indicates strong liquidity. The company holds minimal debt.

The stock: Contango Oil & Gas is down 12% this year, lagging behind major U.S. indices. The stock trades at a price-to-earnings ratio of 15, a discount to the market and oil and gas exploration peers.

The model upgraded hotel and movie theatre operator Marcus (MCS - Get Report) to "buy."

The numbers: Fiscal first-quarter net income decreased 18% to $10 million, or 34 cents a share, as revenue declined 9% to $110 million. Its gross margin dropped from 40% to 30% and its operating margin fell from 20% to 17%. Just $8 million of cash and a quick ratio of 0.3 indicate weak liquidity. But a debt-to-equity ratio of 0.7 indicates reasonable leverage.

The stock: Marcus has fallen 16% this year, trailing major U.S. indices. The stock trades at a price-to-earnings ratio of 24, a premium to the market and hotel and resort peers. Shares pay a 2.5% dividend yield.

The model upgraded semiconductor manufacturer MIPS Technologies (MIPS) to "hold."

The numbers: Fiscal fourth-quarter net loss declined to $6 million from a $109 million loss in the year-earlier period. On a per share basis, the company posted a 6 cent profit, compared to a 3 cent loss in the prior year's quarter. Its gross and operating margins dropped from 24% to 2%. A quick ratio of 2.6 demonstrates impressive liquidity. A debt-to-equity ratio of 0.5 indicates conservative leverage.

The stock: MIPS Technologies has surged 235% this year, beating major U.S. indices. The stock trades at a price-to-earnings ratio of 15, a discount to the market and semiconductor peers. The company does not pay dividends.

The model upgraded conglomerate Standex (SXI - Get Report) to "hold."

The numbers: Fiscal fourth-quarter net income grew 5% to $5.7 million, but earnings per share remained flat at 46 cents. Revenue fell 23% to $140 million. Its gross margin remained steady at 32%, but its operating margin climbed from 6% to 7%. A quick ratio of 0.9 indicates less-than-ideal liquidity. A debt-to-equity ratio of 0.5 is below the industry average, demonstrating restrained leverage.

The stock: Standex has risen 1% this year, lagging behind major U.S. indices. The company posted a loss of $1.48 a share in its fiscal third-quarter, breaking a streak of profitability. Shares pay a 1% dividend yield.

-- Reported by Jake Lynch in Boston.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
HITK $43.49 -0.02%
MCF $21.65 0.00%
MCS $20.58 0.00%
SXI $82.30 0.00%
AAPL $132.65 0.00%

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs